Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women

BACKGROUND: XM17 is a recombinant human follicle-stimulating hormone (follitropin alfa) for stimulation of multifollicular development in women undergoing controlled ovarian hyper-stimulation during assisted reproductive therapy and for treatment of anovulation. Manufactured using Chinese hamster ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Lammerich, Andreas, Bias, Peter, Gertz, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509534/
https://www.ncbi.nlm.nih.gov/pubmed/26213478
http://dx.doi.org/10.2147/IJWH.S83418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509534/
https://www.ncbi.nlm.nih.gov/pubmed/26213478
http://dx.doi.org/10.2147/IJWH.S83418

Ejemplares similares